Living skin in the lab: one month to understand aging

Outer Bio has solved a bottleneck that has constrained three decades of anti-aging research: human skin dies within days of extraction, before the biological processes that matter even begin. Its Yuna platform maintains full-thickness human tissue—epidermis, dermis, and immune cells—viable and measurable for four weeks, the duration needed to observe collagen remodeling, chronic low-grade inflammation, and senescent cell accumulation. Tested across 300+ donors spanning different ages, sexes, and skin tones, each compound generates over 30,000 data points; the platform has already amassed 10 terabytes from 10,000 individual treatments. Machine-learning systems trained on Yuna results grow sharper with every test, prioritizing which compounds to screen next across a virtual library of 5.9 million compounds, with plans to scale to billions. For the $100+ billion skincare industry, this represents material progress: only one topical ingredient (retinoids) has earned FDA recognition for visibly improving aging skin across three decades. Yet Yuna's true significance extends beyond cosmetics—the underlying biology it models (senescence, inflammaging, tissue repair loss) mirrors the aging mechanisms longevity researchers pursue across every organ, making skin the ideal proving ground for systemic anti-aging therapeutics.